227 related articles for article (PubMed ID: 37526431)
1. Isolated pulmonary metastases in pancreatic ductal adenocarcinoma: a review of current evidence.
Adekolujo OS; Wahab A; Akanbi MO; Oyasiji T; Hrinczenko B; Alese OB
Cancer Biol Ther; 2023 Dec; 24(1):2198479. PubMed ID: 37526431
[TBL] [Abstract][Full Text] [Related]
2. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer.
Stuart CM; Kirsch MJ; Zhuang Y; Meguid CL; Sugawara T; Colborn KL; Messersmith W; Lieu C; Gleisner AL; Del Chiaro M; Schulick RD; Meguid RA
Surgery; 2023 Sep; 174(3):654-659. PubMed ID: 37391327
[TBL] [Abstract][Full Text] [Related]
4. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK
J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355
[TBL] [Abstract][Full Text] [Related]
5. Surgical Treatment for Pulmonary Metastasis of Pancreatic Ductal Adenocarcinoma: Study of 12 Cases.
Yasukawa M; Kawaguchi T; Kawai N; Tojo T; Taniguchi S
Anticancer Res; 2017 Oct; 37(10):5573-5576. PubMed ID: 28982872
[TBL] [Abstract][Full Text] [Related]
6. Isolated pulmonary recurrence after resection of pancreatic cancer: the effect of patient factors and treatment modalities on survival.
Groot VP; Blair AB; Gemenetzis G; Ding D; Burkhart RA; van Oosten AF; Molenaar IQ; Cameron JL; Weiss MJ; Yang SC; Wolfgang CL; He J
HPB (Oxford); 2019 Aug; 21(8):998-1008. PubMed ID: 30777697
[TBL] [Abstract][Full Text] [Related]
7. Significance of pulmonary resection in patients with metachronous pulmonary metastasis from pancreatic ductal adenocarcinoma: a retrospective cohort study.
Mashiko T; Nakano A; Masuoka Y; Yamamoto S; Ozawa S; Nakagohri T
BMC Surg; 2021 May; 21(1):237. PubMed ID: 33952223
[TBL] [Abstract][Full Text] [Related]
8. Impact of Driver Mutations on the Evolution of Isolated Metachronous Lung Metastasis of Pancreatic Ductal adenocarcinoma.
Vitellius C; Griveaux O; Morvant B; Pedrono E; Venara A; Ingster O; Baize N; Dincuff E; Rousselet MC; Guardiola P; Caroli-Bosc FX
Mol Diagn Ther; 2020 Aug; 24(4):443-449. PubMed ID: 32524539
[TBL] [Abstract][Full Text] [Related]
9. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
10. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
11. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability.
Koti S; Demyan L; Deutsch G; Weiss M
Ann Surg Oncol; 2024 Jun; 31(6):4031-4041. PubMed ID: 38502293
[TBL] [Abstract][Full Text] [Related]
12. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?
Ebrahimi A; Cham J; Puglisi L; De Shadarevian M; Hermel DJ; Spierling Bagsic SR; Sigal D
Cancer Med; 2023 May; 12(9):10243-10253. PubMed ID: 36916531
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan heterogeneity in pancreatic ductal adenocarcinoma: Primary tumors compared to sites of metastasis.
Placencio-Hickok VR; Lauzon M; Moshayedi N; Guan M; Kim S; Nissen N; Lo S; Pandol S; Larson BK; Gong J; Hendifar AE; Osipov A
Pancreatology; 2022 Jan; 22(1):92-97. PubMed ID: 34657790
[TBL] [Abstract][Full Text] [Related]
14. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.
Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW;
Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732
[TBL] [Abstract][Full Text] [Related]
15. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.
Steele CW; Oien KA; McKay CJ; Jamieson NB
Pancreas; 2011 Nov; 40(8):1165-71. PubMed ID: 22001830
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of paraaortic lymph node metastases in patients with ductal adenocarcinoma of the pancreatic head.
Petrova E; Mazzella E; Trojan J; Koch C; Schulze F; Bechstein WO; Schnitzbauer AA
Eur J Surg Oncol; 2023 May; 49(5):996-1000. PubMed ID: 36586788
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of para-aortic lymph node status in resected pancreatic ductal adenocarcinoma and invasive intraductal papillary mucinous neoplasm - Time to consider a reclassification?
Linder S; Holmberg M; Engstrand J; Ghorbani P; Sparrelid E
Surg Oncol; 2022 May; 41():101735. PubMed ID: 35287096
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection.
Gablo N. A; Procházka V; Hlavsa J; Kiss I; Srovnal J; Kala Z; Slabý O
Klin Onkol; 2019; 32(Suppl 1):174-176. PubMed ID: 31064193
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.
Decoster C; Gilabert M; Autret A; Turrini O; Oziel-Taieb S; Poizat F; Giovannini M; Viens P; Iovanna J; Raoul JL
Oncotarget; 2016 Jul; 7(29):45649-45655. PubMed ID: 27286454
[TBL] [Abstract][Full Text] [Related]
20. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
